Analyst
Barclays
Equibles does not estimate personal net worth.
Jonathan Anwin is recorded as Analyst at Barclays. Jonathan Anwin has spoken on 2 earnings calls across 2 companies, most recently for SCHOTT Pharma AG & Co. KGaA on August 12, 2026. Those appearances were for SCHOTT Pharma AG & Co. KGaA (SHTPY) and SCHOTT Pharma AG & Co. KGaA. The companies whose calls Jonathan Anwin spoke on are classified in the Healthcare sector.
“My first question is on the updated guidance for FY26. You obviously upgraded that based on the renegotiation of contracts with your class pre-filter in the customer.”
“My first question is on the updated guidance for FY26. You obviously upgraded that based on the renegotiation of contracts with your class pre-filter in the customer.”
Barclays
Analyst
Transcript header (unverified)
Medical Instruments & Supplies · Healthcare
SCHOTT Pharma AG & Co. KGaA
Medical Instruments & Supplies · Healthcare
Quarterly statement (9M 2026)
SCHOTT Pharma AG & Co. KGaA
